Investor Dossier
EQT Life Sciences
active
Typeinvestor
Location—
Portfolio (2 investments)
ImCheck Therapeutics
Series C · Jun 2022
€96.0M
Amolyt Pharma
Series C · Jan 2023
€128.1M
Investor Dossier
Series C · Jun 2022
€96.0M
Series C · Jan 2023
€128.1M